James N Wilson - Net Worth and Insider Trading

James N Wilson Net Worth

The estimated net worth of James N Wilson is at least $52 Million dollars as of 2024-11-13. James N Wilson is the Director of Corcept Therapeutics Inc and owns about 901,067 shares of Corcept Therapeutics Inc (CORT) stock worth over $52 Million. Details can be seen in James N Wilson's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James N Wilson has not made any transactions after 2016-11-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of James N Wilson

To

James N Wilson Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, James N Wilson owns 1 companies in total, including Corcept Therapeutics Inc (CORT) .

Click here to see the complete history of James N Wilson’s form 4 insider trades.

Insider Ownership Summary of James N Wilson

Ticker Comapny Transaction Date Type of Owner
CORT Corcept Therapeutics Inc 2016-11-11 director

James N Wilson Latest Holdings Summary

James N Wilson currently owns a total of 1 stock. James N Wilson owns 901,067 shares of Corcept Therapeutics Inc (CORT) as of November 11, 2016, with a value of $52 Million.

Latest Holdings of James N Wilson

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CORT Corcept Therapeutics Inc 2016-11-11 901,067 57.79 52,072,662

Holding Weightings of James N Wilson


James N Wilson Form 4 Trading Tracker

According to the SEC Form 4 filings, James N Wilson has made a total of 0 transactions in Corcept Therapeutics Inc (CORT) over the past 5 years. The most-recent trade in Corcept Therapeutics Inc is the sale of 158,812 shares on November 11, 2016, which brought James N Wilson around $1 Million.

Insider Trading History of James N Wilson

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

James N Wilson Trading Performance

GuruFocus tracks the stock performance after each of James N Wilson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James N Wilson is -28.87%. GuruFocus also compares James N Wilson's trading performance to market benchmark return within the same time period. The performance of stocks bought by James N Wilson within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how James N Wilson's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of James N Wilson

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 4.58 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 1.27 LIMIT LIMIT LIMIT LIMIT LIMIT

James N Wilson Ownership Network

Ownership Network List of James N Wilson

No Data

Ownership Network Relation of James N Wilson

Insider Network Chart

James N Wilson Owned Company Details

What does Corcept Therapeutics Inc do?

Who are the key executives at Corcept Therapeutics Inc?

James N Wilson is the director of Corcept Therapeutics Inc. Other key executives at Corcept Therapeutics Inc include Chief Development Officer William Guyer , CHIEF FINANCIAL OFFICER Gary Charles Robb , and Chief Accounting Officer Joseph Douglas Lyon .

Corcept Therapeutics Inc (CORT) Insider Trades Summary

Over the past 18 months, James N Wilson made no insider transaction in Corcept Therapeutics Inc (CORT). Other recent insider transactions involving Corcept Therapeutics Inc (CORT) include a net sale of 70,000 shares made by Joseph Douglas Lyon , a net sale of 28,750 shares made by Swisher Daniel N Jr , and a net sale of 225,000 shares made by Sean Maduck .

In summary, during the past 3 months, insiders sold 44,101 shares of Corcept Therapeutics Inc (CORT) in total and bought 0 shares, with a net sale of 44,101 shares. During the past 18 months, 517,899 shares of Corcept Therapeutics Inc (CORT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 517,899 shares.

Corcept Therapeutics Inc (CORT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Corcept Therapeutics Inc Insider Transactions

No Available Data

James N Wilson Mailing Address

Above is the net worth, insider trading, and ownership report for James N Wilson. You might contact James N Wilson via mailing address: Amylin Pharmaceuticals Inc, 9360 Towne Centre Dr, San Diego Ca 92121.